Gameto, a biotechnology firm, has raised $33 million in Sequence B funding, which it would use to help the scientific improvement of its in vitro maturation (IVM) product, known as Fertilo. New York Metropolis-based Gameto develops therapy options for girls's well being, together with infertility. Fertilo mimics an ovarian surroundings by utilizing specifically developed ovarian help cells to mature eggs […]
